Marc Semigran
Overview
Explore the profile of Marc Semigran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heitner S, Jacoby D, Lester S, Owens A, Wang A, Zhang D, et al.
Ann Intern Med
. 2019 Apr;
170(11):741-748.
PMID: 31035291
Background: Mavacamten, an orally administered, small-molecule modulator of cardiac myosin, targets underlying biomechanical abnormalities in obstructive hypertrophic cardiomyopathy (oHCM). Objective: To characterize the effect of mavacamten on left ventricular outflow...
2.
Kohli P, Staziaki P, Janjua S, Addison D, Hallett T, Hennessy O, et al.
PLoS One
. 2018 Jul;
13(7):e0201376.
PMID: 30059544
Heart Failure (HF) and chronic obstructive pulmonary disease (COPD) are morbid diseases that often coexist. In patients with coexisting disease, COPD is an independent risk factor for readmission and mortality....
3.
Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, et al.
J Acoust Soc Am
. 2017 Nov;
142(4):EL401.
PMID: 29092550
This pilot study used acoustic speech analysis to monitor patients with heart failure (HF), which is characterized by increased intracardiac filling pressures and peripheral edema. HF-related edema in the vocal...
4.
Reddy Y, Lewis G, Shah S, LeWinter M, Semigran M, Davila-Roman V, et al.
Circ Heart Fail
. 2017 May;
10(5).
PMID: 28476756
Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02742129.
5.
Maurer M, Elliott P, Comenzo R, Semigran M, Rapezzi C
Circulation
. 2017 Apr;
135(14):1357-1377.
PMID: 28373528
Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis in everyday clinical practice, but the diagnosis continues to be made in patients with late-stage disease, suggesting that...
6.
El-Jawahri A, Paasche-Orlow M, Matlock D, Stevenson L, Lewis E, Stewart G, et al.
Circulation
. 2016 Jul;
134(1):52-60.
PMID: 27358437
Background: Conversations about goals of care and cardiopulmonary resuscitation (CPR)/intubation for patients with advanced heart failure can be difficult. This study examined the impact of a video decision support tool...
7.
Damp J, Givertz M, Semigran M, Alharethi R, Ewald G, Felker G, et al.
JACC Heart Fail
. 2016 Mar;
4(5):380-8.
PMID: 26970832
Objectives: This study explored the association of vascular hormones with myocardial recovery and clinical outcomes in peripartum cardiomyopathy (PPCM). Background: PPCM is an uncommon disorder with unknown etiology. Angiogenic imbalance...
8.
Niehaus E, Malhotra R, Cocca-Spofford D, Semigran M, Lewis G
J Card Fail
. 2015 Jun;
21(8):694-7.
PMID: 26028263
Background: Iron deficiency is associated with reduced functional capacity and increased mortality in patients with heart failure with reduced ejection fraction (HFrEF). Correction of iron deficiency in HFrEF patients with...
9.
Vachiery J, Adir Y, Barbera J, Champion H, Coghlan J, Cottin V, et al.
Turk Kardiyol Dern Ars
. 2015 Feb;
42 Suppl 1:130-41.
PMID: 25697040
Pulmonary hypertension (PH), a common complication of left heart diseases (LHD), negatively impacts symptoms, exercise capacity, and outcome. Although the true prevalence of PH-LHD is unknown, a subset of patients...
10.
Vachiery J, Adir Y, Barbera J, Champion H, Coghlan J, Cottin V, et al.
J Am Coll Cardiol
. 2013 Dec;
62(25 Suppl):D100-8.
PMID: 24355634
Pulmonary hypertension (PH), a common complication of left heart diseases (LHD), negatively impacts symptoms, exercise capacity, and outcome. Although the true prevalence of PH-LHD is unknown, a subset of patients...